Ignite Creation Date:
2025-12-24 @ 9:24 PM
Ignite Modification Date:
2026-04-05 @ 11:07 PM
Study NCT ID:
NCT05807932
Status:
RECRUITING
Last Update Posted:
2024-05-01
First Post:
2023-03-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Venetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAML
Sponsor:
Organization: